Table 2.
Description of the Evaluation Samples
| ART Chart Reviews (N = 2122) | TB Chart Reviews (N = 2071) | |||||
|---|---|---|---|---|---|---|
| Total | Pretraining | Posttraining | Total | Pretraining | Posttraining | |
| Demographic Factor | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) |
| Gender | ||||||
| Female | 1455 (68.6) | 698 (65.0) | 757 (72.2) | 897 (43.3) | 463 (43.6) | 434 (43.1) |
| Male | 661 (31.1) | 373 (34.7) | 288 (27.5) | 1166 (56.3) | 596 (56.1) | 570 (56.5) |
| Not documented | 6 (0.3) | 3 (0.3) | 3 (0.3) | 8 (0.4) | 4 (0.4) | 4 (0.4) |
| Age (years) | ||||||
| 8–14a | – | – | – | 34 (1.6) | 17 (1.6) | 17 (1.7) |
| 15–24 | 312 (14.7) | 115 (10.7) | 197 (18.8) | 305 (14.7) | 165 (15.5) | 140 (13.9) |
| 25–34 | 822 (38.7) | 414 (38.6) | 408 (38.9) | 598 (28.9) | 312 (29.4) | 286 (28.4) |
| 35–44 | 553 (26.1) | 296 (27.6) | 257 (24.5) | 503 (24.3) | 249 (23.4) | 254 (25.2) |
| ≥45 | 421 (19.8) | 240 (22.3) | 181 (17.3) | 552 (26.7) | 278 (26.2) | 274 (27.2) |
| Unknown | 14 (0.7) | 9 (0.8) | 5 (0.5) | 79 (3.8) | 42 (4.0) | 37 (3.7) |
| Year of diagnosisb | ||||||
| Before 2011 | 599 (28.2) | 336 (31.3) | 263 (25.1) | – | – | – |
| 2011 | 246 (11.6) | 177 (16.5) | 69 (6.6) | – | – | – |
| 2012 | 525 (24.7) | 361 (33.6) | 164 (15.7) | – | – | – |
| 2013 | 449 (21.2) | 0 (0.0) | 449 (42.8) | – | – | – |
| Not documented | 303 (14.3) | 200 (18.6) | 103 (9.8) | – | – | – |
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; TB, tuberculosis.
aPediatric HIV patients (<15 years) were not assessed in this evaluation.
bYear of TB diagnosis was not documented. HIV patients were diagnosed with HIV as early as 1993.